Search by Drug Name or NDC
NDC 67457-0914-05 Ultiva 1 mg/mL Details
Ultiva 1 mg/mL
Ultiva is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional LLC. The primary component is REMIFENTANIL HYDROCHLORIDE.
Product Information
| NDC | 67457-0914 |
|---|---|
| Product ID | 67457-914_fa6f720d-01ea-4c46-9ff1-1680af34b37f |
| Associated GPIs | 65100087102150 |
| GCN Sequence Number | 028226 |
| GCN Sequence Number Description | remifentanil HCl VIAL 5 MG INTRAVEN |
| HIC3 | H3H |
| HIC3 Description | OPIOID ANALGESIC, ANESTHETIC ADJUNCT AGENTS |
| GCN | 07210 |
| HICL Sequence Number | 011931 |
| HICL Sequence Number Description | REMIFENTANIL HCL |
| Brand/Generic | Brand |
| Proprietary Name | Ultiva |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Remifentanil Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | REMIFENTANIL HYDROCHLORIDE |
| Labeler Name | Mylan Institutional LLC |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| Marketing Category | NDA |
| Application Number | NDA020630 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 67457-0914-05 (67457091405)
| NDC Package Code | 67457-914-05 |
|---|---|
| Billing NDC | 67457091405 |
| Package | 10 VIAL, GLASS in 1 CARTON (67457-914-05) / 10 mL in 1 VIAL, GLASS (67457-914-00) |
| Marketing Start Date | 2020-04-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |